Definitive Contract HHSN272201100040C
Award Date
9/26/11
Potential Completion Date
4/17/17
Potential Value
$2.6M
Federal Agency
National Institute of Allergy and Infectious Diseases
Ultimate Awardee
Lovelace Biomedical Research Institute
NAICS Category
541711 - Research and Development in Biotechnology
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Cost No Fee
Place of Performance
Albuquerque, NM 87108, USA
Solicitation Procedures
Basic Research
Number Of Offers Received
17
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for a Delivery Order under the National Institute of Allergy and Infectious Diseases (NIAID) Animal Models of Infectious Diseases 2010-2017 Indefinite Delivery, Indefinite Quantity (IDIQ) contract. The $1,513,255.77 cost-plus-fixed-fee contract was awarded to Lovelace Biomedical and Environmental Research Institute, Inc. (LBERI), a subsidiary of Lovelace Biomedical Research Institute, to provide a non-human primate model for testing the immunogenicity and...
This federal contract was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the U.S. Department of Health and Human Services, to The Children's Hospital of Philadelphia (CHOP) for "Targeted Clinical Research to Address Select Viral Infections." The $5,835,169.39 definitive contract is for a 7-year period ending in May 2024. It does not have a set-aside designation. Under this contract, CHOP leads a multi-site observational study on human adenovirus...
The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a $716,374 delivery order contract to Lovelace Biomedical Research Institute. Under the terms of the firm fixed price contract, Lovelace Biomedical Research Institute will conduct a Good Laboratory Practice repeat dose toxicology study for BPL-24910 in support of the Comprehensive and Rapid Response for NIAID Research Programs major program code. Performance...
The National Institutes of Health's National Institute of Allergy and Infectious Diseases awarded a $2,000 firm fixed price delivery order against an unspecified contract vehicle to Lovelace Biomedical Research Institute. The delivery order is for comprehensive and rapid response services to support NIAID's research programs over a one year period from September 2021 through August 2022. The place of performance will be in Bethesda, Maryland. No set aside designation or subcontractors were...
The National Institute of Allergy and Infectious Diseases (NIAID) awarded a $486,301.00 cost-plus-fixed-fee delivery order contract to the Lovelace Biomedical Research Institute, a not-for-profit contract research organization. Under this contract, the Lovelace Biomedical Research Institute will perform the transfer, validation, and qualification of bioanalytical methods for the detection of cabotegravir and levonorgestrel in rat and nonhuman primate plasma. This work is being conducted...
The Department of Health and Human Services' National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a $20,168 delivery order to Lovelace Biomedical Research Institute under the Resources to Advance Pediatrics and HIV Prevention Science indefinite-delivery/indefinite-quantity master contract. Lovelace will perform guaranteed minimum work related to advancing pediatrics and HIV prevention science from April 2023 through June 2024 in Albuquerque, New Mexico. The...
Leidos Biomedical Research Inc. was awarded a $4,311,311 delivery order against the National Institutes of Health National Institute of Allergy and Infectious Diseases Joint Clinical Research Program. The delivery order supports immunologic and infectious disease clinical research at Children's National Medical Center through September 1, 2027. No set-aside designation was used for this award. The prime contractor, Leidos Biomedical Research, will conduct the research in coordination with the...
This federal contract award was issued by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the Department of Health and Human Services, to Leidos Biomedical Research Inc. The $134,064,345 cost-plus-fixed-fee contract is for Leidos Biomedical Research to manage, oversee, execute, and publish findings of a prospective observational study on adult and pediatric patients with unknown febrile illness. The contract does not have a set-aside designation. As...
This federal contract award is for a definitive contract with the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, to provide scientific support for research on the structural biology of infectious diseases. The $32,903,521 contract, which has no set-aside designation, was awarded to Seattle Children's Hospital, doing business as Seattle Children's Research Institute, a leading non-profit pediatric research institution. The contract...
This $537,319.27 federal delivery order contract was awarded by the National Institute of Allergy and Infectious Diseases (NIAID) to the Lovelace Biomedical Research Institute, a not-for-profit preclinical contract research organization. The contract supports the TRANSFER AND VALIDATION OF BIOANALYTICAL METHOD FOR DETECTION OF CABOTEGRAVIR IN RAT PLASMA under NIAID's Comprehensive Resources for HIV Microbicides and Biomedical Prevention program. This work is being performed as a task order under...